SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-000421
Filing Date
2023-01-09
Accepted
2023-01-09 06:55:54
Documents
15
Period of Report
2023-01-09
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K gls-20230109.htm   iXBRL 8-K 62803
2 EX-99.1 gls-ex99_1.htm EX-99.1 493
3 PDF COURTESY COPY gls-ex99_1.pdf EX-99.1 2079056
  Complete submission text file 0000950170-23-000421.txt   3078607

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT gls-20230109_pre.xml EX-101.PRE 12976
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT gls-20230109.xsd EX-101.SCH 3092
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT gls-20230109_lab.xml EX-101.LAB 17357
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT gls-20230109_def.xml EX-101.DEF 13676
9 EXTRACTED XBRL INSTANCE DOCUMENT gls-20230109_htm.xml XML 6597
Mailing Address 501 BOYLSTON STREET, SUITE 6102 BOSTON MA 02116
Business Address 501 BOYLSTON STREET, SUITE 6102 BOSTON MA 02116 857-327-7737
GELESIS HOLDINGS, INC. (Filer) CIK: 0001805087 (see all company filings)

IRS No.: 844730610 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39362 | Film No.: 23516480
SIC: 2834 Pharmaceutical Preparations